| P50 | author | Rosalba Torrisi | Q56850429 |
| | Luca Di Tommaso | Q57022086 |
| P2093 | author name string | A Santoro | |
| | G Masci | |
| | M Zuradelli | |
| | I Garassino | |
| | C Gandini | |
| | A Losurdo | |
| P2860 | cites work | Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer | Q28376841 |
| | Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer | Q33257718 |
| | Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy. | Q36274479 |
| | Metronomic chemotherapy: new rationale for new directions | Q37763502 |
| | Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial | Q43212287 |
| | Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer. | Q46365348 |
| | Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. | Q46830983 |
| | Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer Patients | Q58211907 |
| | Risk of leukemia after chemotherapy and radiation treatment for breast cancer | Q68137055 |
| | Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels | Q77683633 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metastatic breast cancer | Q12859063 |
| | methotrexate | Q422232 |
| P304 | page(s) | 275 | |
| P577 | publication date | 2012-10-18 | |
| P1433 | published in | Ecancermedicalscience | Q27722239 |
| P1476 | title | Low-dose "metronomic chemotherapy" with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit | |
| P478 | volume | 6 | |